Financials
- Market Capitalization 570.23 M
- Employee 21
- Founded 2012
- CEO N/A
- Website www.immixbio.com
- Headquarter Delaware, United States
- FIGI BBG00HLCWH09
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2825 | DRUG Bright Minds Biosciences Inc. - common stock | 76.01 USD | +2.67% | +8.77% | +27.58% | +206.86% | 580.40 M USD | ||
| 2829 | ALT Altimmune, Inc. - Common Stock | 2.99 USD | +2.05% | -3.86% | +12.83% | -28.81% | 581.48 M USD | ||
| 2850 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 9.00 USD | -0.55% | +1.01% | +10.70% | +1.35% | 560.92 M USD | ||
| 2888 | ARVN Arvinas, Inc. - Common Stock | 8.26 USD | -0.12% | -3.17% | +10.58% | -11.18% | 532.95 M USD |
Frequently asked questions about Immix Biopharma, Inc. - Common Stock
What is the Immix Biopharma, Inc. - Common Stock stock price today?
The current price of Immix Biopharma, Inc. - Common Stock (IMMX) is 10.48. Over the past 24 hours, the stock has changed by -1.87%. Follow the IMMX chart for real-time price dynamics.
What is the stock ticker of Immix Biopharma, Inc. - Common Stock?
Immix Biopharma, Inc. - Common Stock trades under the ticker IMMX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immix Biopharma, Inc. - Common Stock stock going up?
IMMX has changed by -3.76% over the last week, +23.29% over the last month, and +271.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immix Biopharma, Inc. - Common Stock net income for the last quarter?
Immix Biopharma, Inc. - Common Stock reported net income of -10.09 M for the last quarter. The previous quarter showed -10.69 M, which means net income changed by +5.62%.
How many employees does Immix Biopharma, Inc. - Common Stock have?
As of the latest available data, Immix Biopharma, Inc. - Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immix Biopharma, Inc. - Common Stock EBITDA?
Immix Biopharma, Inc. - Common Stock EBITDA is -10.7 M, and its EBITDA margin is 45.51 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immix Biopharma, Inc. - Common Stock stock?
You can buy Immix Biopharma, Inc. - Common Stock (IMMX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immix Biopharma, Inc. - Common Stock stock?
Investing in Immix Biopharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMMX chart and related analysis on metatrader.com as part of your research.